SIRT1 promotes tumorigenesis of hepatocellular carcinoma through PI3K/PTEN/AKT signaling
- PMID: 22552445
- DOI: 10.3892/or.2012.1788
SIRT1 promotes tumorigenesis of hepatocellular carcinoma through PI3K/PTEN/AKT signaling
Retraction in
-
[Retracted] SIRT1 promotes tumorigenesis of hepatocellular carcinoma through PI3K/PTEN/AKT signaling.Oncol Rep. 2023 Jun;49(6):110. doi: 10.3892/or.2023.8547. Epub 2023 Apr 21. Oncol Rep. 2023. PMID: 37083064 Free PMC article.
Abstract
SIRT1 is the human orthologue of SIR2, a conserved NAD-dependent protein deacetylase that regulates longevity in yeast and in Caenorhabditis elegans. Overexpression of SIRT1 in cancer tissue, compared with normal tissue, has been demonstrated, suggesting that SIRT1 may act as a tumor promoter. The function of SIRT1 in liver cancer has not been elucidated. In the present study, SIRT1 re-expression or knockdown was induced in hepatoma cell lines and liver normal cell lines. Our study demonstrated that overexpression of SIRT1 promoted mitotic entry of liver cells, cell growth and proliferation and inhibited apoptosis. The apoptosis involved caspase-3 and caspase-7, and was related to the PTEN/PI3K/AKT signaling pathway. The results demonstrate that SIRT1 promotes tumorigenesis of hepatocellular carcinoma (HCC) through the PTEN/PI3K/AKT signaling pathway. SIRT1 may serve as a novel target for selective killing of cancer versus normal liver cells.
Similar articles
-
SIRT1 promotes proliferation and inhibits apoptosis of human malignant glioma cell lines.Neurosci Lett. 2012 Sep 13;525(2):168-72. doi: 10.1016/j.neulet.2012.07.025. Epub 2012 Jul 31. Neurosci Lett. 2012. PMID: 22867969
-
MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway.Cancer Sci. 2017 Apr;108(4):620-631. doi: 10.1111/cas.13177. Epub 2017 Apr 19. Cancer Sci. 2017. PMID: 28132399 Free PMC article.
-
Alpha1-ACT Functions as a Tumour Suppressor in Hepatocellular Carcinoma by Inhibiting the PI3K/AKT/mTOR Signalling Pathway via Activation of PTEN.Cell Physiol Biochem. 2017;41(6):2289-2306. doi: 10.1159/000475648. Epub 2017 Apr 26. Cell Physiol Biochem. 2017. PMID: 28456796
-
Rap2B knockdown suppresses malignant progression of hepatocellular carcinoma by inactivating the PTEN/PI3K/Akt and ERK1/2 pathways.Mol Cell Biochem. 2020 Mar;466(1-2):55-63. doi: 10.1007/s11010-020-03687-w. Epub 2020 Feb 12. Mol Cell Biochem. 2020. PMID: 32052247
-
Long Noncoding RNA lncARSR Promotes Doxorubicin Resistance in Hepatocellular Carcinoma via Modulating PTEN-PI3K/Akt Pathway.J Cell Biochem. 2017 Dec;118(12):4498-4507. doi: 10.1002/jcb.26107. Epub 2017 Jun 9. J Cell Biochem. 2017. PMID: 28464252
Cited by
-
Occludin: a gatekeeper of brain Infection by HIV-1.Fluids Barriers CNS. 2023 Oct 16;20(1):73. doi: 10.1186/s12987-023-00476-7. Fluids Barriers CNS. 2023. PMID: 37840143 Free PMC article. Review.
-
MicroRNA-30a-3p overexpression improves sepsis-induced cell apoptosis in vitro and in vivo via the PTEN/PI3K/AKT signaling pathway.Exp Ther Med. 2018 Feb;15(2):2081-2087. doi: 10.3892/etm.2017.5644. Epub 2017 Dec 15. Exp Ther Med. 2018. PMID: 29434809 Free PMC article.
-
Prognostic and clinicopathologic significance of SIRT1 expression in hepatocellular carcinoma.Oncotarget. 2016 Dec 22;8(32):52357-52365. doi: 10.18632/oncotarget.14096. eCollection 2017 Aug 8. Oncotarget. 2016. PMID: 28881735 Free PMC article.
-
Low SIRT3 expression correlates with poor differentiation and unfavorable prognosis in primary hepatocellular carcinoma.PLoS One. 2012;7(12):e51703. doi: 10.1371/journal.pone.0051703. Epub 2012 Dec 14. PLoS One. 2012. PMID: 23272146 Free PMC article.
-
p33ING1b regulates acetylation of p53 in oral squamous cell carcinoma via SIR2.Cancer Cell Int. 2020 Aug 18;20:398. doi: 10.1186/s12935-020-01489-0. eCollection 2020. Cancer Cell Int. 2020. PMID: 32831651 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials